Clinical trial
The Effects of Apixaban on Platelet Function Profiles in Patients With Stable Coronary Artery Disease: The ACER Pilot Study
NCT07853612 is registered in ClinicalTrials.gov with The University of The West Indies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Apixaban on Platelet Function Profiles in Patients With Stable Coronary Artery Disease: The ACER Pilot Study
- Lead sponsor
- The University of The West Indies
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- September 3, 2026
- Completion date
- October 1, 2028
- Enrollment
- 16 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, high on-treatment platelet reactivity (htpr)